Clinical trials
Phase 2 Frailty trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2016 | 2 |
| 2018 | 5 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Not yet recruiting | 4 |
| Recruiting | 4 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 2 |
| Suspended | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 4 |
| National Institute on Aging (NIA) | 2 |
| TNF Pharmaceuticals, Inc. | 2 |
| University of Rochester | 2 |
| Amgen | 1 |
| Anne B. Newman | 1 |
| Bijan Najafi, PhD | 1 |
| European Institute of Oncology | 1 |
| Gladwin, Mark, MD | 1 |
| Haukeland University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Frailty | 31 |
| Inflammation | 7 |
| Sarcopenia | 7 |
| Diabetes Mellitus | 2 |
| Neoplasms | 2 |
| Renal Insufficiency, Chronic | 2 |
| Anemia | 1 |
| Arthritis | 1 |
| Atrophy | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.